varun TBRC’s Post

View profile for varun TBRC

Digita Marketing at The Business Research Company

The Levothyroxine Sodium market is poised for growth, with a value of $3.73 billion in 2023, projected to reach $3.90 billion in 2024 at a 4.4% CAGR. By 2028, it is expected to hit $4.65 billion. Key growth drivers include heightened awareness of hypothyroidism, expanded insurance coverage, and the introduction of cost-effective generics. Innovations like gel capsules, such as IBSA Pharma's Tirosint launched in 2023, are enhancing patient care. North America leads the market, while Asia-Pacific is set to grow rapidly due to rising healthcare investments. For more Info: https://lnkd.in/gH_BCZJ9 #HealthcareInnovation #Pharmaceuticals #ThyroidHealth #Levothyroxine #MarketGrowth #HealthCare #tbrc

Ranjini K.

Associate Consultant @ EY | Global Vice-Chairwoman @ TechLabs

7mo

Intriguing insights on Levothyroxine's thriving market driven by accessibility. varun tbrc

Like
Reply

To view or add a comment, sign in

Explore topics